Fabry Disease: A Disorder of Childhood Onset

Raphael Schiffmann1, Markus Ries2

  • 1Institute of Metabolic Disease, Baylor Research Institute, Dallas, Texas.

Pediatric Neurology
|August 25, 2016
PubMed

Insights

Fabry disease, a genetic disorder, increases risks for vasculopathy and organ damage. Early diagnosis and treatment are crucial, but overdiagnosis must be avoided.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Neurology

Background:

  • Fabry disease is an X-linked disorder of glycosphingolipids.
  • It elevates the risk of systemic vasculopathy, ischemic stroke, neuropathy, cardiac dysfunction, and kidney disease.
  • Caused by GLA gene variants, its incidence may be underestimated.

Purpose of the Study:

  • To review the clinical manifestations and management of Fabry disease.
  • To highlight the challenges in diagnosis, including under- and overdiagnosis.
  • To discuss current and emerging therapeutic strategies.

Main Methods:

  • Extensive PubMed search on Fabry disease.
  • Analysis based on cumulative clinical experience.

Main Results:

  • Complications are often nonspecific and mimic common disorders.
  • Some GLA gene variants are benign, necessitating caution against overdiagnosis and unjustified enzyme replacement therapy.
  • Current specific therapies show modest clinical effects, with novel agents under development.

Conclusions:

  • Fabry disease is a treatable genetic risk factor for various organ complications.
  • The condition may be frequently overlooked or occasionally overdiagnosed.
  • Standard therapies are essential for managing organ damage and slowing disease progression.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1000
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
986
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.7K
Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.5K